![Mark Shtilerman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Shtilerman
Direttore/Membro del Consiglio presso Stelexis Therapeutics LLC
Provenienza dei contatti di primo grado di Mark Shtilerman
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Stelexis Therapeutics LLC
![]() Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Mark Shtilerman tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Ipsen Bioinnovation Ltd.
![]() Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | President | |
MODERNA, INC. | Biotechnology | Founder | |
Cystetic Medicines, Inc.
![]() Cystetic Medicines, Inc. Pharmaceuticals: MajorHealth Technology Cystetic Medicines, Inc. is a clinical-stage biotechnology company located in Champaign, IL. The company is pioneering the development of small molecule anion channel prosthetics to restore protein function in people with cystic fibrosis (CF). The company utilizes a proprietary inhaled dry powder formulation that enables improved dose consistency and high efficiency delivery to the airways. Currently, they are focused on the development of CM001, a novel inhalable small molecule therapeutic designed to restore ion balance and host defenses in the lungs to treat CF. The company was founded in 2020 based on the work of Dr. Martin Burke of the University of Illinois at Urbana-Champaign and Dr. Michael Welsh at the University of Iowa. | Pharmaceuticals: Major | Director/Board Member | |
Deerfield Management Co. LP (Private Equity)
![]() Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Investment Managers | Private Equity Investor | |
Avadel Pediatrics, Inc.
![]() Avadel Pediatrics, Inc. Pharmaceuticals: MajorHealth Technology Avadel Pediatrics, Inc. markets and distributes pediatric pharmaceutical products and medical devices. It offers AcipHex Sprinkle, Cefaclor for Oral Suspension, Flexichamber and Karbinal ER products. The company was founded by Peter W. Steelman in 2004 and is headquartered in Charlotte, NC. | Pharmaceuticals: Major | Chief Executive Officer | |
FSC Laboratories, Inc.
![]() FSC Laboratories, Inc. Drugstore ChainsRetail Trade FSC Laboratories, Inc. engages in development of prescription medicines and medical devices. The company was founded by Peter W. Steelman in April 16, 2004 and is headquartered in Charlotte, NC. | Drugstore Chains | Chief Executive Officer | |
DePauw University | College/University | Undergraduate Degree | |
Columbia Business School | College/University | Masters Business Admin | |
Ophirex, Inc.
![]() Ophirex, Inc. Miscellaneous Commercial ServicesCommercial Services Ophirex, Inc. develops antidotes to snakebite. The company was founded by Jerry D. Harrison and Matthew Lewin and is headquartered in Corte Madera, CA. | Miscellaneous Commercial Services | Director/Board Member | |
New York Stem Cell Foundation, Inc. | Investment Trusts/Mutual Funds | Chief Executive Officer | |
Convelo Therapeutics, Inc.
![]() Convelo Therapeutics, Inc. BiotechnologyHealth Technology Convelo Therapeutics, Inc. develops medicines that unlock the regenerative capacity of the central nervous system. The company was founded by Paul Tesar and Drew Adams in 2016 and is headquartered in Cleveland, OH. | Biotechnology | Chief Executive Officer | |
University of Sunderland | College/University | Doctorate Degree | |
INTELLIA THERAPEUTICS, INC. | Biotechnology | Founder | |
University of Helsinki | College/University | Doctorate Degree | |
University of Toronto | College/University | Graduate Degree | |
ModernaTX, Inc.
![]() ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
KINEMED INC | Miscellaneous Commercial Services | President | |
Novo Nordisk, Inc.
![]() Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal | |
Roche Ltd.
![]() Roche Ltd. Financial ConglomeratesFinance Roche Ltd. provides investment services. | Financial Conglomerates | Corporate Officer/Principal | |
CYMABAY THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
University of Geneva | College/University | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 18 |
Regno Unito | 3 |
Cina | 2 |
Finlandia | 2 |
Canada | 2 |
Settori
Health Technology | 11 |
Consumer Services | 7 |
Finance | 4 |
Commercial Services | 3 |
Retail Trade | 2 |
Posizioni
Director/Board Member | 9 |
Founder | 8 |
President | 5 |
Chief Executive Officer | 5 |
Corporate Officer/Principal | 4 |
Contatti più connessi
Insiders | |
---|---|
Derrick J. Rossi | 10 |
Patrick James Doyle | 8 |
Peter W. Steelman | 8 |
Ulrich Steidl | 1 |
Bob Jackson | 1 |
- Borsa valori
- Insiders
- Mark Shtilerman
- Connessioni Società